- Home
- ADXN vs ATHE Comparison
ADXN vs ATHE Comparison
Compare ADXN & ATHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- ATHE
- Stock Information
- Founded
- ADXN 2002
- ATHE 1997
- Country
- ADXN Switzerland
- ATHE Australia
- Employees
- ADXN N/A
- ATHE N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- ATHE Biotechnology: Pharmaceutical Preparations
- Sector
- ADXN Health Care
- ATHE Health Care
- Exchange
- ADXN Nasdaq
- ATHE Nasdaq
- Market Cap
- ADXN 8.5M
- ATHE 10.1M
- IPO Year
- ADXN N/A
- ATHE N/A
- Fundamental
- Price
- ADXN $7.79
- ATHE $2.16
- Analyst Decision
- ADXN Strong Buy
- ATHE Strong Buy
- Analyst Count
- ADXN 1
- ATHE 2
- Target Price
- ADXN $30.00
- ATHE $6.00
- AVG Volume (30 Days)
- ADXN 45.6K
- ATHE 118.8K
- Earning Date
- ADXN 11-22-2024
- ATHE 12-24-2024
- Dividend Yield
- ADXN N/A
- ATHE N/A
- EPS Growth
- ADXN N/A
- ATHE N/A
- EPS
- ADXN 0.06
- ATHE N/A
- Revenue
- ADXN $701,260.00
- ATHE $2,681,669.00
- Revenue This Year
- ADXN N/A
- ATHE N/A
- Revenue Next Year
- ADXN N/A
- ATHE N/A
- P/E Ratio
- ADXN $1.05
- ATHE N/A
- Revenue Growth
- ADXN N/A
- ATHE 2.63
- 52 Week Low
- ADXN $5.39
- ATHE $1.00
- 52 Week High
- ADXN $27.90
- ATHE $3.19
- Technical
- Relative Strength Index (RSI)
- ADXN 42.74
- ATHE 64.93
- Support Level
- ADXN $7.14
- ATHE $2.18
- Resistance Level
- ADXN $8.40
- ATHE $2.45
- Average True Range (ATR)
- ADXN 0.62
- ATHE 0.25
- MACD
- ADXN 0.07
- ATHE 0.03
- Stochastic Oscillator
- ADXN 27.39
- ATHE 74.63
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
About ATHE Alterity Therapeutics Limited
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.